Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Labstyle Innovat (DRIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 26,143
  • Shares Outstanding, K 36,821
  • Annual Sales, $ 7,390 K
  • Annual Income, $ -17,800 K
  • 60-Month Beta -1.27
  • Price/Sales 3.61
  • Price/Cash Flow N/A
  • Price/Book 2.73
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.80
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/21/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/18
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.43
  • Growth Rate Est. (year over year) +232,425.58%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.63 +17.10%
on 03/25/19
0.87 -15.21%
on 03/22/19
+0.06 (+9.08%)
since 03/18/19
3-Month
0.58 +27.19%
on 03/18/19
0.87 -15.21%
on 03/22/19
-0.11 (-12.70%)
since 01/18/19
52-Week
0.58 +27.19%
on 03/18/19
2.15 -65.69%
on 04/26/18
-1.01 (-57.85%)
since 04/18/18

Most Recent Stories

More News
Dario® Elevates Digital Therapeutics Capabilities by Further Enhancing Patient Experience

Global digital therapeutics innovator, DarioHealth Corp. (NASDAQ: DRIO), today announced the launch of a new version of its acclaimed Dario® system and DarioEngage(TM) platform.

DRIO : 0.74 (+3.90%)
DarioHealth Signs Leading Functional Medicine Clinic to DarioEngage(TM) Remote Digital Diabetes Platform

Global #digitaltherapeutics innovator DarioHealth Corp. (Nasdaq: DRIO) today announced an agreement with Cupertino-based Auer Integrative Health's Functional Medicine and Chiropractic, a Silicon Valley...

DRIO : 0.74 (+3.90%)
DarioHealth Partners With Glytec on Outpatient Diabetes Management

Global digital therapeutics innovator, DarioHealth Corp. (NASDAQ: DRIO), today announced a joint marketing agreement with Glytec, the market leader and pioneer of insulin titration solutions for use across...

DRIO : 0.74 (+3.90%)
DarioHealth Reports Fourth Quarter and Year End 2018 Record Results

Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO), today reported record financial and operational results for the full-year ended on December 31, 2018.

DRIO : 0.74 (+3.90%)
DarioHealth Granted License by Health Canada to Sell Dario Smart Glucose Meters for Lightning® Connector Enabled iPhones

Global digital therapeutics innovator, DarioHealth Corp. (NASDAQ: DRIO), announced today the receipt of a license from Health Canada to sell its Dario(TM) Blood Glucose Monitoring System for Lightning...

DRIO : 0.74 (+3.90%)
DarioHealth to Host Fourth Quarter and Year End 2018 Conference Call March 25, 2019

Global digital therapeutics innovation leader DarioHealth Corp. (NASDAQ: DRIO) today announced it will release its fourth quarter and year-end 2018 results on Monday, March 25, and host a conference call...

DRIO : 0.74 (+3.90%)
DarioHealth Signs National Distribution Deal in the U.S. With Better Living Now for Its Digital Health Products

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today it has signed an agreement with Better Living Now (BLN), a leading national...

DRIO : 0.74 (+3.90%)
DarioHealth Reports First Quarter 2018 Results

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today reported financial and operational results for the first quarter ended on March...

DRIO : 0.74 (+3.90%)
DarioHealth Releases Next Generation Version 4.0 of its Award-Winning App

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced the availability of its award-winning next-generation app, version 4.0....

DRIO : 0.74 (+3.90%)
DarioHealth Ramps up Commercialization Capabilities

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today it has hired U.S.-based digital health executive JC Muyl as Head of...

DRIO : 0.74 (+3.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade DRIO with:

Business Summary

DarioHealth Corp. creates mobile and digital tools. The company's product the Dario(TM) Smart Diabetes Management Solution, is a platform for diabetes management which combines blood glucose meter, native smart phone app, website portal and treatment tools to users living with diabetes, their doctors...

See More

Key Turning Points

2nd Resistance Point 0.78
1st Resistance Point 0.76
Last Price 0.74
1st Support Level 0.72
2nd Support Level 0.70

See More

52-Week High 2.15
Fibonacci 61.8% 1.55
Fibonacci 50% 1.37
Fibonacci 38.2% 1.18
Last Price 0.74
52-Week Low 0.58

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar